HRS-9813
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Guangdong Hengrui Pharmaceutical Co., Ltd
Overview
HRS-9813 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
HRS-9813 clinical trials
Explore related
Medical disclaimer. This page summarizes research about HRS-9813 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.